Resminostat hydrochloride

CAS: 1187075-34-8

Ref. 3D-BR162323

Produktinformation

• Name: Resminostat hydrochloride
• Marke: Biosynth
• Beschreibung: Resminostat hydrochloride is a histone deacetylase inhibitor that blocks the expression of genes that regulate the progression of cerebral vascular disease. It inhibits acetylation and methylation, which are epigenetic mechanisms that regulate gene expression. Resminostat hydrochloride is a promising drug for the treatment of cerebral vascular diseases due to its ability to inhibit protein synthesis in tissues and prevent infarction in animals. This drug also regulates cellular death and reduces cerebral vascular disease by regulating regulatory proteins, such as nuclear factor-κB (NF-κB).

Chemische Eigenschaften

• Molekulargewicht: 385.87 g/mol
• Formel: C₁₆H₁₉N₃O₄S·HCl
• Reinheit: Min. 95%